InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: abeta post# 208319

Monday, 01/14/2019 1:52:41 PM

Monday, January 14, 2019 1:52:41 PM

Post# of 704484


At the end of the day - don't know how he got the numbers so wrong
about the MGMT Methylated GBM CETEG trial



Abeta,

I hope Dr. Dietmar Krex was more accurate in his presentation.
Dr. Dietmar Krex is one of the authors of the publication.

Gliale Hirntumoren – Aktuelle Therapiekonzepte (GBM Tumors - Current Therapy Concepts)

Klinischer Abend Mittwoch, 05. Dezember 2018 17.00 – 19.00 Uhr
17.35 Uhr

Aktuelle therapierelevante Studienergebnisse (DCVax, CeTeG, NF-14) Prof. Dr. Dietmar Krex Klinik und Poliklinik für Neurochirurgie
https://www.carus-management.de/wp-content/uploads/2018/08/Klin.-Abend-_final_05.12.18.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News